127 related articles for article (PubMed ID: 4079945)
1. Murine antibody response to the glycolipid asialo GM1 adsorbed to Salmonella.
Higgins TJ
Mol Immunol; 1985 Nov; 22(11):1265-71. PubMed ID: 4079945
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
Solomon FR; Higgins TJ
Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
[TBL] [Abstract][Full Text] [Related]
3. Preparation of monoclonal antibodies against a glycolipid asialo GM1.
Shimada S; Iwata D
Microbiol Immunol; 1987; 31(9):923-33. PubMed ID: 3696009
[TBL] [Abstract][Full Text] [Related]
4. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
5. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
Suttles J; Schwarting GA; Stout RD
J Immunol; 1986 Mar; 136(5):1586-91. PubMed ID: 2936802
[TBL] [Abstract][Full Text] [Related]
7. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
8. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
9. The glycolipid asialo GM1 as a new differentiation antigen of fetal thymocytes.
Habu S; Kasai M; Nagai Y; Tamaoki N; TAda T; Herzenberg LA; Okumura K
J Immunol; 1980 Nov; 125(5):2284-8. PubMed ID: 6968778
[TBL] [Abstract][Full Text] [Related]
10. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
Staats HF; Oakes JE; Lausch RN
J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS).
Witkin SS; Sonnabend J; Richards JM; Purtilo DT
Clin Exp Immunol; 1983 Nov; 54(2):346-50. PubMed ID: 6652964
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a mouse monoclonal antibody to the glycolipid asialo-GM1.
Jacquemart F; Millot G; Goujet-Zalc C; Mahouy G; Zalc B
Hybridoma; 1988 Aug; 7(4):323-31. PubMed ID: 3169804
[TBL] [Abstract][Full Text] [Related]
13. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behçet's diseases with neurological manifestations.
Hirano T; Miyajima H; Taniguchi O; Ueda A; Takai S; Hashimoto H; Hirose S; Okumura K
Jpn J Med; 1988 May; 27(2):167-71. PubMed ID: 3418980
[TBL] [Abstract][Full Text] [Related]
14. Ganglio-N-tetraosylceramide (asialo GM1), an antigen common to the brain and immune system: its localization in myelin.
Kusunoki S; Tsuji S; Nagai Y
Brain Res; 1985 May; 334(1):117-24. PubMed ID: 2581667
[TBL] [Abstract][Full Text] [Related]
15. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
16. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
Kawase I; Urdal DL; Brooks CG; Henney CS
Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
[TBL] [Abstract][Full Text] [Related]
17. An immunosuppressive factor interacts with membrane glycolipid asialo-GM1 structure.
Wang KC; Verret CR; Yu RK; Gershon RK; Lee S
Immunobiology; 1987 Mar; 174(2):139-45. PubMed ID: 3596633
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
Riser BL; Laybourn KA; Varani J
Nat Immun Cell Growth Regul; 1988; 7(5-6):305-15. PubMed ID: 3221908
[TBL] [Abstract][Full Text] [Related]
19. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
